Bison Wealth’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,000
Closed -$11K 219
2017
Q4
$11K Hold
5,000
0.01% 208
2017
Q3
$10K Hold
5,000
0.01% 197
2017
Q2
$21K Buy
+5,000
New +$26.9K 0.02% 187

Other funds holding MBVX

Bison Wealth's MBVX Position: Q1 2018 in Review

Bison Wealth sold out of MABVAX THERAPEUTICS HLDGS INC (MBVX) in Q1 2018, closing a stake of 5,000 shares — an estimated $11K sold.

Bison Wealth first reported a position in MBVX in Q2 2017 and held it in 3 quarters. The position peaked at $21K in Q2 2017. 11 funds tracked by Wall St. Rank hold MBVX as of Q1 2018.

  • Bison Wealth reported no remaining MABVAX THERAPEUTICS HLDGS INC position as of Q1 2018 after selling out during the quarter.
  • Bison Wealth sold 5,000 MABVAX THERAPEUTICS HLDGS INC shares in Q1 2018, an estimated $11K.
  • Bison Wealth first reported a position in MABVAX THERAPEUTICS HLDGS INC in Q2 2017 and held it in 3 quarters.
  • Bison Wealth's MABVAX THERAPEUTICS HLDGS INC position peaked at $21K in Q2 2017.
  • 11 funds tracked by Wall St. Rank held MABVAX THERAPEUTICS HLDGS INC as of Q1 2018.

Based on Bison Wealth's 13F filing for Q1 2018, filed 8 May 2018.